GC1 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to GC1 Antibodies

GC1 antibodies refer to immunoglobulins targeting specific isoforms of the GC1 protein, which exists in two distinct biological contexts: (1) Herpes simplex virus type 1 (HSV-1) glycoprotein C1 (gC1) and (2) mitochondrial glutamate carrier GC1 (SLC25A22). These antibodies enable precise detection and functional studies of their respective antigens in virology, cellular biology, and metabolic research. Below is a detailed analysis of their applications, research findings, and comparative data.

HSV-1 Glycoprotein C1 (gC1) Antibodies

Target: HSV-1 glycoprotein C1, a surface protein critical for viral immune evasion and complement regulation.
Applications:

  • Serodiagnosis: Distinguishing HSV-1 from HSV-2 infections due to type-specific antibody responses .

  • Mechanistic Studies: Investigating gC1’s role in binding complement component C3 to evade host immunity .

Key Antibody: Mouse monoclonal antibody H633 (SeraCare), validated for immunofluorescence (IFA) and Western blot (WB) .

ParameterHSV-1 gC1 Antibody (H633)
Host SpeciesMouse (IgG1)
PurityProtein G affinity chromatography
Functional ActivityReactivity at 10 µg/ml
Storage-20°C (frozen)

Mitochondrial Glutamate Carrier GC1 (SLC25A22) Antibodies

Target: SLC25A22, a mitochondrial transporter critical for glutamate import and cellular metabolism.
Applications:

  • Insulin Secretion: Studying GC1’s role in glucose-stimulated insulin release in pancreatic β-cells .

  • Mitochondrial Function: Analyzing glutamate transport kinetics and metabolic regulation .

Key Antibodies:

  1. Rabbit polyclonal (ab137614): Reacts with human/mouse SLC25A22; suitable for WB, IHC, ICC/IF .

  2. Rabbit polyclonal (A306408): Validated for WB and ICC/IF; tested in knockout models .

ParameterMitochondrial GC1 Antibody (ab137614)Mitochondrial GC1 Antibody (A306408)
Host SpeciesRabbitRabbit
ImmunogenRecombinant SLC25A22 fragmentRecombinant SLC25A22 fragment
DilutionsWB: 1:500–1:2,000; ICC/IF: 1:50–1:200WB: 1:500–1:1,000; ICC/IF: 1:50–1:200
ValidationHuman/mouseHuman/mouse/rat (KO/KD models)

HSV-1 gC1 Antibodies in Virology

  • Complement Evasion: gC1 binds human C3, inhibiting complement-mediated viral neutralization. Antibodies against gC1 block this interaction, enhancing host immune defense .

  • Serodiagnosis: gC1 and gG1 show 96.1% correlation in Western blot assays, enabling accurate HSV-1 detection .

Mitochondrial GC1 Antibodies in Metabolic Research

  • Insulin Secretion: GC1 knockdown reduces glucose-stimulated insulin secretion by 23% in β-cells, restored by exogenous glutamate .

  • Mitochondrial Transport: GC1-specific antibodies confirm its localization to the inner mitochondrial membrane and role in glutamate/H⁺ symport .

StudyObjectiveKey Finding
Role of GC1 in pancreatic β-cellsGC1 knockdown ↓ insulin secretion (23%)
GC1 localization and functionMitochondrial membrane localization
GC1 expression in knockout modelsConfirmed specificity in SLC25A22 KO cells

Comparative Analysis of GC1 Antibodies

FeatureHSV-1 gC1 AntibodyMitochondrial GC1 Antibody
Target OrganismHSV-1Mammalian cells
Primary UseSerodiagnosisMetabolic/molecular biology
ValidationIFA, WBWB, IHC, ICC/IF
Cross-ReactivityHSV-1-specificHuman/mouse/rat

Challenges and Future Directions

  • Specificity: Cross-reactivity between HSV-1 gC1 and gG1 necessitates rigorous validation in serodiagnosis .

  • Therapeutic Potential: Mitochondrial GC1 antibodies may aid in studying metabolic disorders linked to glutamate transport dysregulation .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
GC1 antibody; At2g19950 antibody; F6F22.2Golgin candidate 1 antibody; AtGC1 antibody; Golgin-84 antibody
Target Names
GC1
Uniprot No.

Target Background

Function
GC1 Antibody targets a Golgi matrix protein that plays a crucial role in vesicle tethering to Golgi membranes. This protein is essential for maintaining the structural integrity of the Golgi apparatus.
Database Links

KEGG: ath:AT2G19950

STRING: 3702.AT2G19950.2

UniGene: At.39769

Subcellular Location
Golgi apparatus membrane; Single-pass type II membrane protein. Note=Probably located to cisternal rims of cis or medial Golgi.

Q&A

Here’s a structured FAQ collection for researchers studying GC1 Antibody, synthesized from academic literature and optimized for methodological rigor:

Advanced Research Questions

How do researchers resolve contradictions in GC1-mediated immune response data across aging cohorts?

Discrepancies in CD4/CD8 ratios or cytokine responses (e.g., CNR vs. CR groups ) require:

  • Multi-parametric analysis: Combine immune cell frequencies (NKT cells, B cells), cytokine levels (IFN-γ, IL-6), and gene expression (FOXO1, SOD1) .

  • Longitudinal sampling: Track antibody titers pre/post-vaccination to distinguish age-related declines from transient effects .

What methodologies quantify GC1 Antibody’s role in germinal center (GC) affinity maturation?

  • Multiphoton microscopy: Visualize GC B-cell clonal competition (e.g., loss of 70% diversity by day 14) .

  • Single-cell BCR sequencing: Link somatic hypermutation rates to antibody affinity (KD < 10 nM threshold) .

Methodological Challenges & Solutions

How to design studies analyzing GC1 Antibody’s functional implications in immunosenescence?

  • Cohort stratification: Classify older adults into cytokine responders (CR) vs. non-responders (CNR) using IL-2/IL-10 ratios .

  • Gene expression profiling: Compare longevity-associated pathways (e.g., redox regulation, DNA repair) via RNA-seq (Table S7 ).

What high-throughput techniques identify GC1 cross-reactivity with related antigens?

  • Phage display libraries: Screen >10⁶ variants for off-target binding to gG-2 or gD .

  • Surface plasmon resonance (SPR): Measure kinetic parameters (kon/koff) against gC-1 homologs .

Data Tables

Table 1: Key Biomarkers for GC1 Antibody Functional Studies

ParameterCR Group (Mean ± SE)CNR Group (Mean ± SE)MethodSource
CD8+ naïve cells12.3% ± 1.25.8% ± 0.9Flow cytometry
SOD1 expression2.1-fold ↑1.1-fold ↑RNA-seq (FPKM)
Antibody titer (H1N1)1:40 (log₂ 5.3)1:20 (log₂ 4.3)ELISA

Table 2: GC Clonal Diversity Metrics

GC StageClones SeededClones Retained (Day 14)Affinity (KD, nM)Source
Early2006085 ± 12
Late150189.7 ± 2.1

Research Recommendations

  • For biomarker discovery: Integrate GC1 binding data with telomere length (qPCR) and plasma cytokine arrays (Luminex) .

  • For vaccine studies: Prioritize CNR cohorts for adjuvanted vaccines, given their preserved response to influenza vaccination despite immunosenescence .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.